0001645469-17-000002.txt : 20170328 0001645469-17-000002.hdr.sgml : 20170328 20170328133928 ACCESSION NUMBER: 0001645469-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170328 DATE AS OF CHANGE: 20170328 EFFECTIVENESS DATE: 20170328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-283447 FILM NUMBER: 17718316 BUSINESS ADDRESS: STREET 1: 5 REVERE DRIVE, SUITE 200 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 6143958936 MAIL ADDRESS: STREET 1: 5 REVERE DRIVE, SUITE 200 CITY: NORTHBROOK STATE: IL ZIP: 60062 D 1 primary_doc.xml X0707 D LIVE 0001645469 Monopar Therapeutics 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL ILLINOIS 60062 6143958936 DELAWARE None None Corporation true 2015 Chandler D. Robinson 5 Revere Dr, Suite 200 Northbrook IL ILLINOIS 60062 Executive Officer Director Christopher M. Starr 5 Revere Dr, Suite 200 Northbrook IL ILLINOIS 60062 Executive Officer Director Andrew P. Mazar 5 Revere Dr, Suite 200 Northbrook IL ILLINOIS 60062 Executive Officer Director Michael J. Brown 5 Revere Dr, Suite 200 Northbrook IL ILLINOIS 60062 Director Biotechnology Decline to Disclose 06b false true false true false 120000 10000000 0 10000000 false 0 0 0 0 In the ordinary course of business, the issuer likely may use some of the proceeds of the offering to pay salaries and consulting fees to certain of its executive officers and directors. false Monopar Therapeutics Chandler D. Robinson Chandler D. Robinson CEO 2017-03-28